摘要
适应证点评是中成药处方点评中的难点,且目前没有共同认可的点评标准。该文通过对天津中医药大学第二附属医院2022年7—12月点评的中成药处方进行统计分析并结合日常工作经验,总结中成药适应证点评不合格发生的原因,梳理中成药适应证点评难点,并提出可行化对策,以期为中成药点评工作的标准化和规范化发展提供参考。
Prescription indication reviews are the problematic points in reviewing prescriptions of Chinese patent medicines.However,there is no commonly recognized review standard.This article conducted a statistical analysis of the prescriptions reviewed by pharmacists from July to December 2022 in the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine.Combined with work experience,we analyzed the results and reasons for unqualified indication reviews,combed out the difficulties of the indications review in Chinese patent medicines,and proposed feasible strategies to provide support for the standardization and standardized development in reviewing prescriptions of Chinese patent medicines.
作者
魏文浩
莫愁
何颖
WEI Wenhao;MO Chou;HE Ying(Department of Pharmacy,Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300250,China;Department of Traditional Chinese Medicine,Tianjin Vocational College of Bioengineering,Tianjin 300462,China)
出处
《医药导报》
CAS
北大核心
2024年第3期390-393,共4页
Herald of Medicine
关键词
中成药
适应证
处方点评
难点与对策
Chinese patent medicine
Indications
Prescription reviews
Difficulties and countermeasures
